{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T21:48:13Z","timestamp":1785361693822,"version":"3.55.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["annallergy.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Allergy, Asthma & Immunology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.anai.2026.03.015","type":"journal-article","created":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T03:45:27Z","timestamp":1774583127000},"page":"225-231.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Honeybee venom immunotherapy: An Australian center experience of more than 15 years"],"prefix":"10.1016","volume":"137","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0868-0541","authenticated-orcid":false,"given":"Michelle","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda J.","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thanh-Thao Adriana","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed B.","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.anai.2026.03.015_bib0001","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1111\/all.13262","article-title":"EAACI guidelines on allergen immunotherapy: hymenoptera venom allergy","volume":"73","author":"Sturm","year":"2018","journal-title":"Allergy"},{"issue":"10","key":"10.1016\/j.anai.2026.03.015_bib0002","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1111\/all.14352","article-title":"Fatal anaphylaxis in Italy: analysis of cause-of-death national data, 2004-2016","volume":"75","author":"Bil\u00f2","year":"2020","journal-title":"Allergy"},{"key":"10.1016\/j.anai.2026.03.015_bib0003","series-title":"Venomous bites and stings 2017\u201318: AIHW","year":"2021"},{"issue":"2","key":"10.1016\/j.anai.2026.03.015_bib0004","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.jaci.2008.10.049","article-title":"Anaphylaxis fatalities and admissions in Australia","volume":"123","author":"Liew","year":"2009","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.anai.2026.03.015_bib0005","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1067\/mai.2001.119028","article-title":"Emergency department anaphylaxis: a review of 142 patients in a single year","volume":"108","author":"Brown","year":"2001","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.anai.2026.03.015_bib0006","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1056\/NEJM197807272990401","article-title":"A controlled trial of immunotherapy in insect hypersensitivity","volume":"299","author":"Hunt","year":"1978","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.anai.2026.03.015_bib0007","doi-asserted-by":"crossref","DOI":"10.2500\/aap.2024.45.240035","article-title":"Efficacy and safety of hymenoptera venom immunotherapy","volume":"45","author":"Kayikci","year":"2024","journal-title":"Allergy Asthma Proc"},{"issue":"5","key":"10.1016\/j.anai.2026.03.015_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.waojou.2021.100536","article-title":"Impact of specific immunotherapy and sting challenge on the quality of life in patients with hymenoptera venom allergy","volume":"14","author":"Eitel","year":"2021","journal-title":"World Allergy Organ J"},{"issue":"4","key":"10.1016\/j.anai.2026.03.015_bib0009","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1111\/all.70176","article-title":"Cost-effectiveness of venom immunotherapy in preventing severe bee and wasp sting reactions","volume":"81","author":"Sturm","year":"2026","journal-title":"Allergy"},{"issue":"1","key":"10.1016\/j.anai.2026.03.015_bib0010","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jaip.2024.08.025","article-title":"Risk factors for severe sting reactions and side effects during venom immunotherapy","volume":"13","author":"Sturm","year":"2025","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"20","key":"10.1016\/j.anai.2026.03.015_bib0011","first-page":"2391","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood J Am Soc Hematol"},{"issue":"2","key":"10.1016\/j.anai.2026.03.015_bib0012","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.jaci.2004.04.029","article-title":"Clinical features and severity grading of anaphylaxis","volume":"114","author":"Brown","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2026.03.015_bib0013","series-title":"Treatment Plan for Subcutaneous Allergen Immunotherapy (SCIT)","year":"2024"},{"issue":"1","key":"10.1016\/j.anai.2026.03.015_bib0014","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.anai.2012.09.014","article-title":"Efficacy of venom immunotherapy given every 3 or 4 months: a prospective comparison with the conventional regimen","volume":"110","author":"Simioni","year":"2013","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"9","key":"10.1016\/j.anai.2026.03.015_bib0015","doi-asserted-by":"crossref","DOI":"10.1111\/pai.70195","article-title":"Efficacy and safety of subcutaneous venom immunotherapy in children: a 24-year experience in a pediatric tertiary care center","volume":"36","author":"Giovannini","year":"2025","journal-title":"Pediatr Allergy Immunol"},{"issue":"2","key":"10.1016\/j.anai.2026.03.015_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaip.2025.09.038","article-title":"Omalizumab enables bee venom desensitisation in patients with anaphylactic reactions to venom immunotherapy","volume":"14","author":"Capper","year":"2026","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"3","key":"10.1016\/j.anai.2026.03.015_bib0017","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2012.03.024","article-title":"Over-and underestimated parameters in severe Hymenoptera venom\u2013induced anaphylaxis: cardiovascular medication and absence of urticaria\/angioedema","volume":"130","author":"Stoevesandt","year":"2012","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.anai.2026.03.015_bib0018","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.anai.2015.03.001","article-title":"Hymenoptera venom immunotherapy while maintaining cardiovascular medication: safe and effective","volume":"114","author":"Stoevesandt","year":"2015","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"2","key":"10.1016\/j.anai.2026.03.015_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2021.02.043","article-title":"Routine KIT p. D816V screening identifies clonal mast cell disease in patients with Hymenoptera allergy regularly missed using baseline tryptase levels alone","volume":"148","author":"\u0160elb","year":"2021","journal-title":"J Allergy Clin Immunol"},{"issue":"9","key":"10.1016\/j.anai.2026.03.015_bib0020","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1111\/all.16084","article-title":"High burden of clonal mast cell disorders and hereditary \u03b1-tryptasemia in patients who need Hymenoptera venom immunotherapy","volume":"79","author":"Koro\u0161ec","year":"2024","journal-title":"Allergy"},{"issue":"3","key":"10.1016\/j.anai.2026.03.015_bib0021","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.jaci.2008.11.018","article-title":"Clonal mast cell disorders in patients with systemic reactions to Hymenoptera stings and increased serum tryptase levels","volume":"123","author":"Bonadonna","year":"2009","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.anai.2026.03.015_bib0022","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.anai.2020.03.007","article-title":"Predictors of severe anaphylaxis in Hymenoptera venom allergy: the importance of absence of urticaria and angioedema","volume":"125","author":"Chapsa","year":"2020","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"11","key":"10.1016\/j.anai.2026.03.015_bib0023","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1034\/j.1398-9995.2000.00587.x","article-title":"Side-effects of insect venom immunotherapy: results from an EAACI multicenter study. European Academy of Allergology and Clinical Immunology","volume":"55","author":"Mosbech","year":"2000","journal-title":"Allergy"},{"issue":"12","key":"10.1016\/j.anai.2026.03.015_bib0024","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1111\/cea.12997","article-title":"Overcoming severe adverse reactions to venom immunotherapy using anti-Ig E antibodies in combination with a high maintenance dose","volume":"47","author":"Stretz","year":"2017","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.anai.2026.03.015_bib0025","doi-asserted-by":"crossref","first-page":"57","DOI":"10.5414\/ALX02175E","article-title":"Long-term impact of hymenoptera venom immunotherapy on clinical course, immune parameters, and psychosocial aspects","volume":"5","author":"Adelmeyer","year":"2021","journal-title":"Allergol Select"},{"issue":"6","key":"10.1016\/j.anai.2026.03.015_bib0026","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1067\/mai.2000.105708","article-title":"Safety of a two-day ultrarush insect venom immunotherapy protocol in comparison with protocols of longer duration and involving a larger number of injections","volume":"105","author":"Brehler","year":"2000","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.anai.2026.03.015_bib0027","article-title":"Hymenoptera venom immunotherapy: tolerance and efficacy of an ultrarush protocol versus a rush and a slow conventional protocol","volume":"2012","author":"Patella","year":"2012","journal-title":"J Allergy"},{"issue":"11","key":"10.1016\/j.anai.2026.03.015_bib0028","doi-asserted-by":"crossref","first-page":"618","DOI":"10.20344\/amp.9695","article-title":"Reasons for declining venom immunotherapy","volume":"31","author":"Carneiro-Le\u00e3o","year":"2018","journal-title":"Acta Med Port"},{"issue":"1","key":"10.1016\/j.anai.2026.03.015_bib0029","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.anai.2016.10.031","article-title":"Stinging insect hypersensitivity: a practice parameter update 2016","volume":"118","author":"Golden","year":"2017","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"1","key":"10.1016\/j.anai.2026.03.015_bib0030","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12948-015-0030-z","article-title":"Risk of anaphylaxis in patients with large local reactions to hymenoptera stings: a retrospective and prospective study","volume":"13","author":"Pucci","year":"2015","journal-title":"Clin Mol Allergy"},{"issue":"6","key":"10.1016\/j.anai.2026.03.015_bib0031","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1111\/j.1365-2222.2009.03230.x","article-title":"Immunotherapy improves health-related quality of life of adult patients with dermal reactions following yellow jacket stings","volume":"39","author":"Oude Elberink","year":"2009","journal-title":"Clin Exp Allergy"}],"container-title":["Annals of Allergy, Asthma & Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120626001213?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120626001213?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T09:56:49Z","timestamp":1785319009000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1081120626001213"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S1081120626001213"],"URL":"https:\/\/doi.org\/10.1016\/j.anai.2026.03.015","relation":{},"ISSN":["1081-1206"],"issn-type":[{"value":"1081-1206","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Honeybee venom immunotherapy: An Australian center experience of more than 15 years","name":"articletitle","label":"Article Title"},{"value":"Annals of Allergy, Asthma & Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anai.2026.03.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}